Abstract
Carbohydrate 19-9 antigen (CA 19-9) is considered a specific marker of pancreatobiliary adenocarcinomas, but slight increase of its levels can be found in several non-malignant diseases of the liver, such as autoimmune hepatitis. We describe a case of marked CA 19-9 elevation (up to 898.0 U/ml) in a patient with autoimmune hepatitis. Laboratory and instrumental examinations excluded malignant diseases. Immunohistochemical analysis for CA 19-9 and MIB-1, performed on liver biopsy, showed reactivity in inflammatory areas, in particular in bile ductule cells and hepatocytes in ductular metaplasia, suggesting that these cells could be involved in CA 19-9 serum levels increase. After steroids, the clinical picture improved and all the laboratory parameters normalised.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 603-607 |
| Numero di pagine | 6 |
| Rivista | International Journal of Immunopathology and Pharmacology |
| Volume | 18 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2005 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
Keywords
- autoimmune hepatitis
- ca 19.9
- steroidal therapy
Fingerprint
Entra nei temi di ricerca di 'Normalisation of high CA 19-9 values in autoimmune hepatitis after steroidal treatment.'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver